Icu Medical Stock Analysis

ICUI Stock  USD 148.09  0.00  0.00%   
ICU Medical is undervalued with Real Value of 176.54 and Target Price of 203.4. The main objective of ICU Medical stock analysis is to determine its intrinsic value, which is an estimate of what ICU Medical is worth, separate from its market price. There are two main types of ICU Medical's stock analysis: fundamental analysis and technical analysis.
The ICU Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ICU Medical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

ICU Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.85. Some equities with similar Price to Book (P/B) outperform the market in the long run. ICU Medical has Price/Earnings To Growth (PEG) ratio of 1.7. The entity recorded a loss per share of 4.83. The firm had not issued any dividends in recent years. ICU Medical had 3:2 split on the 18th of March 2002. ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California. I C operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 15300 people. To learn more about ICU Medical call Vivek Jain at 949 366 2183 or check out https://www.icumed.com.

ICU Medical Quarterly Total Revenue

629.8 Million

ICU Medical Investment Alerts

ICU Medical generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 2.38 B. Net Loss for the year was (117.69 M) with profit before overhead, payroll, taxes, and interest of 824.78 M.
Over 99.0% of the company shares are owned by institutional investors
Latest headline from simplywall.st: ICU Medical, Inc.s Shares Lagging The Industry But So Is The Business

ICU Medical Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ICU Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
26th of February 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

ICU Largest EPS Surprises

Earnings surprises can significantly impact ICU Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2005-02-02
2004-12-31-0.13-0.110.0215 
1998-02-02
1997-12-310.120.140.0216 
1997-10-16
1997-09-300.10.120.0220 
View All Earnings Estimates

ICU Medical Environmental, Social, and Governance (ESG) Scores

ICU Medical's ESG score is a quantitative measure that evaluates ICU Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of ICU Medical's operations that may have significant financial implications and affect ICU Medical's stock price as well as guide investors towards more socially responsible investments.

ICU Medical Thematic Classifications

In addition to having ICU Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Obamacare Repeal Idea
Obamacare Repeal
Large healthcare related equities associated with Obamacare
Baby Boomer Prospects Idea
Baby Boomer Prospects
Mega stocks, funds and ETFs that tend to appeal to people considering retirement from the work force

ICU Stock Institutional Investors

Shares
Schroder Investment Management Group2024-12-31
499.8 K
Neuberger Berman Group Llc2024-12-31
478.7 K
Fmr Inc2024-12-31
475.9 K
Northern Trust Corp2024-12-31
402.3 K
Citadel Advisors Llc2024-12-31
391.5 K
Silvercrest Asset Management Group Llc2024-12-31
358.4 K
Btim Corp2024-12-31
317.2 K
Segall Bryant & Hamill2024-12-31
306.8 K
Charles Schwab Investment Management Inc2024-12-31
304.2 K
Blackrock Inc2024-12-31
3.7 M
Vanguard Group Inc2024-12-31
2.7 M
Note, although ICU Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ICU Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.71 B.

ICU Profitablity

The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.06)(0.06)
Return On Capital Employed 0.01  0.01 
Return On Assets(0.03)(0.03)
Return On Equity(0.06)(0.06)

Management Efficiency

ICU Medical has return on total asset (ROA) of 0.0142 % which means that it generated a profit of $0.0142 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0576) %, meaning that it created substantial loss on money invested by shareholders. ICU Medical's management efficiency ratios could be used to measure how well ICU Medical manages its routine affairs as well as how well it operates its assets and liabilities. The ICU Medical's current Return On Tangible Assets is estimated to increase to -0.06. The current Return On Capital Employed is estimated to decrease to 0.01. As of now, ICU Medical's Total Current Assets are increasing as compared to previous years. The ICU Medical's current Other Current Assets is estimated to increase to about 363.3 M, while Net Tangible Assets are forecasted to increase to (373.7 M).
Last ReportedProjected for Next Year
Book Value Per Share 80.58  84.61 
Tangible Book Value Per Share(8.54)(8.12)
Enterprise Value Over EBITDA 117.74  123.63 
Price Book Value Ratio 1.93  3.58 
Enterprise Value Multiple 117.74  123.63 
Price Fair Value 1.93  3.58 
Enterprise Value436.6 M243.3 M
ICU Medical benefits from a management team that prioritizes both innovation and efficiency. We analyze these priorities to gauge the stock's future performance.
Operating Margin
0.0731
Profit Margin
(0.05)
Beta
0.736
Return On Assets
0.0142
Return On Equity
(0.06)

Technical Drivers

As of the 21st of March, ICU Medical retains the coefficient of variation of (1,971), and Market Risk Adjusted Performance of (0.10). ICU Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the entity's future prices.

ICU Medical Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ICU Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ICU Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

ICU Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ICU Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on ICU Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ICU Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

ICU Medical Outstanding Bonds

ICU Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ICU Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ICU bonds can be classified according to their maturity, which is the date when ICU Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

ICU Medical Predictive Daily Indicators

ICU Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ICU Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

ICU Medical Corporate Filings

F4
17th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
14th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
10th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
27th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
14th of February 2025
Other Reports
ViewVerify
F4
2nd of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
6th of December 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
2nd of December 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

ICU Medical Forecast Models

ICU Medical's time-series forecasting models are one of many ICU Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ICU Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About ICU Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how ICU Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ICU shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ICU Medical. By using and applying ICU Stock analysis, traders can create a robust methodology for identifying ICU entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.03)(0.03)
Operating Profit Margin 0.02  0.02 
Net Loss(0.05)(0.05)
Gross Profit Margin 0.35  0.55 

Current ICU Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ICU analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ICU analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
203.4Buy6Odds
ICU Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most ICU analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ICU stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ICU Medical, talking to its executives and customers, or listening to ICU conference calls.
ICU Analyst Advice Details

ICU Stock Analysis Indicators

ICU Medical stock analysis indicators help investors evaluate how ICU Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ICU Medical shares will generate the highest return on investment. By understating and applying ICU Medical stock analysis, traders can identify ICU Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow254.2 M
Long Term Debt1.5 B
Common Stock Shares Outstanding24.4 M
Total Stockholder EquityB
Tax Provision51.7 M
Quarterly Earnings Growth Y O Y-0.238
Property Plant And Equipment Net496 M
Cash And Short Term Investments308.6 M
Cash308.6 M
Accounts Payable148 M
Net Debt1.3 B
50 Day M A156.5388
Total Current Liabilities556.2 M
Other Operating Expenses2.3 B
Non Current Assets Total2.8 B
Forward Price Earnings19.8413
Non Currrent Assets Other68.1 M
Stock Based Compensation46.9 M

Complementary Tools for ICU Stock analysis

When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Valuation
Check real value of public entities based on technical and fundamental data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Managers
Screen money managers from public funds and ETFs managed around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope